For: | Zhai SS, Yu H, Gu TT, Li YX, Lei Y, Zhang HY, Zhen TH, Gao YG. Lung adenocarcinoma harboring rare epidermal growth factor receptor L858R and V834L mutations treated with icotinib: A case report. World J Clin Cases 2020; 8(17): 3841-3846 [PMID: 32953862 DOI: 10.12998/wjcc.v8.i17.3841] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i17/3841.htm |
Number | Citing Articles |
1 |
Nicholas P. Giustini, Colin C. Pritchard, Nikhil V. Kamat, Manoj P. Menon. EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non–Small-Cell Lung Cancer. JCO Precision Oncology 2024; (8) doi: 10.1200/PO.23.00215
|
2 |
Ye Liu, Yongkang Nie, Yuvaraja Teekaraman. [Retracted] Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/5472446
|